<p>金融巨头对默克公司（Merck &amp; Co.）采取了明显的看跌行动。我们对默克公司（NYSE: MRK）期权历史的分析显示出 17 笔异常交易。</p>
<p>深入细节，我们发现 35% 的交易者持看涨态度，而 41% 则表现出看跌倾向。在我们发现的所有交易中，有 3 笔是看跌期权，总价值为 139,802 美元，14 笔是看涨期权，总价值为 5,333,934 美元。</p>
<h3>预测价格目标</h3>
<p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注默克公司的价格区间为 40.0 美元到 110.0 美元。</p>
<h3>分析成交量与未平仓合约</h3>
<p>评估成交量和未平仓合约是期权交易中的一个战略步骤。这些指标揭示了投资者对默克公司在特定行权价格的期权的流动性和兴趣。以下数据可视化了过去 30 天内与默克公司重大交易相关的看涨和看跌期权的成交量和未平仓合约的波动，行权价格范围为 40.0 美元到 110.0 美元。</p>
<h3>默克公司期权活动分析：过去 30 天</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765818050_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="期权看涨图表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765818050_0.png"/></p>
<h3>值得注意的期权活动：</h3>
<table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价格</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>12/19/25</td>
<td>$61.05</td>
<td>$59.6</td>
<td>$60.3</td>
<td>$40.00</td>
<td>$4.6M</td>
<td>0</td>
<td align="right">772</td>
</tr>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>12/19/25</td>
<td>$29.8</td>
<td>$29.4</td>
<td>$29.8</td>
<td>$70.00</td>
<td>$74.5K</td>
<td>31</td>
<td align="right">25</td>
</tr>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>12/17/27</td>
<td>$17.75</td>
<td>$16.8</td>
<td>$17.8</td>
<td>$95.00</td>
<td>$71.2K</td>
<td>260</td>
<td align="right">40</td>
</tr>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>扫描</td>
<td>看跌</td>
<td>06/18/26</td>
<td>$36.3</td>
<td>$35.55</td>
<td>$35.55</td>
<td>$65.00</td>
<td>$71.1K</td>
<td>258</td>
<td align="right">0</td>
</tr>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>02/20/26</td>
<td>$3.25</td>
<td>$3.2</td>
<td>$3.2</td>
<td>$105.00</td>
<td>$64.0K</td>
<td>4.7K</td>
<td align="right">224</td>
</tr>
</tbody>
</table>
<h3>关于默克公司</h3>
<p>默克公司生产药品以治疗多种疾病，涵盖多个治疗领域，包括心代谢疾病、癌症和感染。在癌症领域，该公司的免疫肿瘤学平台以 Keytruda 为主，是整体销售的重要贡献者。该公司还有一个庞大的疫苗业务，旨在预防儿童疾病，以及用于人乳头瘤病毒的 Gardasil。此外，默克还销售动物健康相关药物。从地理角度来看，公司的 47% 的销售来自美国人类健康（药品和疫苗）。</p>
<h3>默克公司目前的状况如何？</h3>
<ul>
<li>交易量为 5,509,858，MRK 的价格下跌了-0.6%，目前为 99.7 美元。</li>
<li>RSI 指标显示该股票可能接近超买状态。</li>
<li>预计在 50 天内公布财报。</li>
</ul>
<h3>专业分析师对默克公司的评级</h3>
<p>5 位市场专家最近对该股票发布了评级，目标共识价格为 117.4 美元。</p>
<p><strong>检测到异常期权活动：聪明资金在行动</strong></p>
<p>Benzinga Edge 的异常期权板块在市场动向发生之前发现潜在的市场推动者。查看大资金在您喜爱的股票上采取了什么头寸。点击这里访问。
* 来自苏格兰银行的分析师坚持对默克公司的行业表现评级，维持目标价格为 120 美元。
* 来自美国银行证券的分析师维持对默克公司的买入评级，目标价格为 120 美元。
* 高盛的分析师保持对默克公司的买入评级，目标价格为 120 美元。
* 来自富国银行的分析师积极调整评级为超配，并将目标价格调整为 125 美元。
* 摩根士丹利的分析师保持对默克公司的等权重评级，目标价格为 102 美元。</p>
<p>期权交易具有更高的风险和潜在的回报。精明的交易者通过不断学习、调整策略、监控多个指标以及密切关注市场动态来管理这些风险。通过 Benzinga Pro 获取最新的默克公司期权交易实时提醒。</p>

默克

<p>金融巨头对默克公司（Merck & Co）表现出看跌情绪，41% 的交易者看跌，35% 看涨。来自斯科舍银行（Scotiabank）、美国银行证券（B of A Securities）、高盛（Goldman Sachs）、富国银行（Wells Fargo）和摩根士丹利（Morgan Stanley）的分析师已发布评级，目标价格范围在 102 美元到 125 美元之间。默克的交易量为 5,509,858，当前价格为 99.7 美元，下跌 0.6%。相对强弱指数（RSI）指标显示该股票可能被超买。预计将在 50 天内发布财报。Benzinga Edge 强调了异常的期权活动，为市场动向提供了洞察</p>

<p>Financial giants have made a conspicuous bearish move on Merck &amp; Co. Our analysis of options history for Merck &amp; Co (NYSE: MRK) revealed 17 unusual trades.</p>
<div class="lb-trans"><p>金融巨头对默克公司（Merck &amp; Co.）采取了明显的看跌行动。我们对默克公司（NYSE: MRK）期权历史的分析显示出 17 笔异常交易。</p>
</div><p>Delving into the details, we found 35% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $139,802, and 14 were calls, valued at $5,333,934.</p>
<div class="lb-trans"><p>深入细节，我们发现 35% 的交易者持看涨态度，而 41% 则表现出看跌倾向。在我们发现的所有交易中，有 3 笔是看跌期权，总价值为 139,802 美元，14 笔是看涨期权，总价值为 5,333,934 美元。</p>
</div><h3>Projected Price Targets</h3>
<div class="lb-trans"><h3>预测价格目标</h3>
</div><p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $40.0 to $110.0 for Merck &amp; Co during the past quarter.</p>
<div class="lb-trans"><p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注默克公司的价格区间为 40.0 美元到 110.0 美元。</p>
</div><h3>Analyzing Volume &amp; Open Interest</h3>
<div class="lb-trans"><h3>分析成交量与未平仓合约</h3>
</div><p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Merck &amp; Co's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Merck &amp; Co's substantial trades, within a strike price spectrum from $40.0 to $110.0 over the preceding 30 days.</p>
<div class="lb-trans"><p>评估成交量和未平仓合约是期权交易中的一个战略步骤。这些指标揭示了投资者对默克公司在特定行权价格的期权的流动性和兴趣。以下数据可视化了过去 30 天内与默克公司重大交易相关的看涨和看跌期权的成交量和未平仓合约的波动，行权价格范围为 40.0 美元到 110.0 美元。</p>
</div><h3>Merck &amp; Co Option Activity Analysis: Last 30 Days</h3>
<div class="lb-trans"><h3>默克公司期权活动分析：过去 30 天</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765818050_0.png" alt="Options Call Chart" original-src="https://www.benzinga.com/files/images/story/2025/1765818050_0.png"/></p>
<h3>Noteworthy Options Activity:</h3>
<div class="lb-trans"><h3>值得注意的期权活动：</h3>
</div><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$61.05</td>
<td>$59.6</td>
<td>$60.3</td>
<td>$40.00</td>
<td>$4.6M</td>
<td>0</td>
<td align="right">772</td>
</tr>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$29.8</td>
<td>$29.4</td>
<td>$29.8</td>
<td>$70.00</td>
<td>$74.5K</td>
<td>31</td>
<td align="right">25</td>
</tr>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$17.75</td>
<td>$16.8</td>
<td>$17.8</td>
<td>$95.00</td>
<td>$71.2K</td>
<td>260</td>
<td align="right">40</td>
</tr>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$36.3</td>
<td>$35.55</td>
<td>$35.55</td>
<td>$65.00</td>
<td>$71.1K</td>
<td>258</td>
<td align="right">0</td>
</tr>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/20/26</td>
<td>$3.25</td>
<td>$3.2</td>
<td>$3.2</td>
<td>$105.00</td>
<td>$64.0K</td>
<td>4.7K</td>
<td align="right">224</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价格</strong></th>
<th><strong>总交易价格</strong></th>
<th><strong>未平仓合约</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>交易</td>
<td>中性</td>
<td>12/19/25</td>
<td>$61.05</td>
<td>$59.6</td>
<td>$60.3</td>
<td>$40.00</td>
<td>$4.6M</td>
<td>0</td>
<td align="right">772</td>
</tr>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>12/19/25</td>
<td>$29.8</td>
<td>$29.4</td>
<td>$29.8</td>
<td>$70.00</td>
<td>$74.5K</td>
<td>31</td>
<td align="right">25</td>
</tr>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>扫描</td>
<td>看涨</td>
<td>12/17/27</td>
<td>$17.75</td>
<td>$16.8</td>
<td>$17.8</td>
<td>$95.00</td>
<td>$71.2K</td>
<td>260</td>
<td align="right">40</td>
</tr>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>扫描</td>
<td>看跌</td>
<td>06/18/26</td>
<td>$36.3</td>
<td>$35.55</td>
<td>$35.55</td>
<td>$65.00</td>
<td>$71.1K</td>
<td>258</td>
<td align="right">0</td>
</tr>
<tr>
<td>MRK</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>02/20/26</td>
<td>$3.25</td>
<td>$3.2</td>
<td>$3.2</td>
<td>$105.00</td>
<td>$64.0K</td>
<td>4.7K</td>
<td align="right">224</td>
</tr>
</tbody>
</table>
</div><h3>About Merck &amp; Co</h3>
<div class="lb-trans"><h3>关于默克公司</h3>
</div><p>Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).</p>
<div class="lb-trans"><p>默克公司生产药品以治疗多种疾病，涵盖多个治疗领域，包括心代谢疾病、癌症和感染。在癌症领域，该公司的免疫肿瘤学平台以 Keytruda 为主，是整体销售的重要贡献者。该公司还有一个庞大的疫苗业务，旨在预防儿童疾病，以及用于人乳头瘤病毒的 Gardasil。此外，默克还销售动物健康相关药物。从地理角度来看，公司的 47% 的销售来自美国人类健康（药品和疫苗）。</p>
</div><h3>Where Is Merck &amp; Co Standing Right Now?</h3>
<div class="lb-trans"><h3>默克公司目前的状况如何？</h3>
</div><ul>
<li>Trading volume stands at 5,509,858, with MRK's price down by -0.6%, positioned at $99.7.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 50 days.</li>
</ul>
<div class="lb-trans"><ul>
<li>交易量为 5,509,858，MRK 的价格下跌了-0.6%，目前为 99.7 美元。</li>
<li>RSI 指标显示该股票可能接近超买状态。</li>
<li>预计在 50 天内公布财报。</li>
</ul>
</div><h3>Professional Analyst Ratings for Merck &amp; Co</h3>
<div class="lb-trans"><h3>专业分析师对默克公司的评级</h3>
</div><p>5 market experts have recently issued ratings for this stock, with a consensus target price of $117.4.</p>
<div class="lb-trans"><p>5 位市场专家最近对该股票发布了评级，目标共识价格为 117.4 美元。</p>
</div><p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<div class="lb-trans"><p><strong>检测到异常期权活动：聪明资金在行动</strong></p>
</div><p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* An analyst from Scotiabank persists with their Sector Outperform rating on Merck &amp; Co, maintaining a target price of $120.
* Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Merck &amp; Co, targeting a price of $120.
* Consistent in their evaluation, an analyst from Goldman Sachs keeps a Buy rating on Merck &amp; Co with a target price of $120.
* In a positive move, an analyst from Wells Fargo has upgraded their rating to Overweight and adjusted the price target to $125.
* Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Merck &amp; Co with a target price of $102.</p>
<div class="lb-trans"><p>Benzinga Edge 的异常期权板块在市场动向发生之前发现潜在的市场推动者。查看大资金在您喜爱的股票上采取了什么头寸。点击这里访问。
* 来自苏格兰银行的分析师坚持对默克公司的行业表现评级，维持目标价格为 120 美元。
* 来自美国银行证券的分析师维持对默克公司的买入评级，目标价格为 120 美元。
* 高盛的分析师保持对默克公司的买入评级，目标价格为 120 美元。
* 来自富国银行的分析师积极调整评级为超配，并将目标价格调整为 125 美元。
* 摩根士丹利的分析师保持对默克公司的等权重评级，目标价格为 102 美元。</p>
</div><p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Merck &amp; Co options trades with real-time alerts from Benzinga Pro.</p>
<div class="lb-trans"><p>期权交易具有更高的风险和潜在的回报。精明的交易者通过不断学习、调整策略、监控多个指标以及密切关注市场动态来管理这些风险。通过 Benzinga Pro 获取最新的默克公司期权交易实时提醒。</p>
</div>

默克公司的期权：大资金的动向分析